These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7669639)

  • 1. Potent antagonism of calmodulin activity in vitro, but lack of antiproliferative effects on keratinocytes by the novel leukotriene biosynthesis inhibitor MK-886.
    Hegemann L; Hatzelmann A; Grewig S; Schmidt BH
    Br J Dermatol; 1995 Jul; 133(1):41-7. PubMed ID: 7669639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MK-886, a leukotriene biosynthesis inhibitor, induces antiproliferative effects and apoptosis in HL-60 cells.
    Dittmann KH; Mayer C; Rodemann HP; Petrides PE; Denzlinger C
    Leuk Res; 1998 Jan; 22(1):49-53. PubMed ID: 9585079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tiflucarbine as a dual protein kinase C/calmodulin antagonist on proliferation of human keratinocytes and release of reactive oxygen species from human leukocytes.
    Hegemann L; Fruchtmann R; Bonnekoh B; Schmidt BH; Traber J; Mahrle G; Müller-Peddinghaus R; van Rooijen LA
    Arch Dermatol Res; 1991; 283(7):456-60. PubMed ID: 1801655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative effects on keratinocytes of a range of clinically used drugs with calmodulin antagonist activity.
    Mac Neil S; Dawson RA; Crocker G; Tucker WF; Bittiner B; Singleton JG; Hunter T; Tierney DF
    Br J Dermatol; 1993 Feb; 128(2):143-50. PubMed ID: 8457447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of drug-induced inhibition of keratinocyte proliferation: antagonism of calmodulin or inhibition of protein kinase C?
    Hegemann L; Mahrle G
    Br J Dermatol; 1993 Nov; 129(5):644-5. PubMed ID: 8251371
    [No Abstract]   [Full Text] [Related]  

  • 6. Antipsoriatic anthrones with modulated redox properties. 5. Potent inhibition of human keratinocyte growth, induction of keratinocyte differentiation, and reduced membrane damage by novel 10-arylacetyl-1,8-dihydroxy-9(10H)-anthracenones.
    Müller K; Reindl H; Breu K
    J Med Chem; 2001 Mar; 44(5):814-21. PubMed ID: 11262091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of antiproliferative effects of experimental and established antipsoriatic drugs on human keratinocytes, using a simple 96-well-plate assay.
    Pol A; Bergers M; Schalkwijk J
    In Vitro Cell Dev Biol Anim; 2003; 39(1-2):36-42. PubMed ID: 12892525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of novel leukotriene--based anti-asthma drugs: MK-886 and MK-571.
    Young RN
    Agents Actions Suppl; 1991; 34():179-87. PubMed ID: 1793062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation of human fibroblast and keratinocyte growth by the protein kinase C inhibitor GF 109203X.
    Le Panse R; Coulomb B; Mitev V; Bouchard B; Lebreton C; Dubertret L
    Mol Pharmacol; 1994 Sep; 46(3):445-51. PubMed ID: 7935324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new class of leukotriene biosynthesis inhibitor: the development of MK-0591.
    Prasit P; Belley M; Blouin M; Brideau C; Chan C; Charleson S; Evans JF; Frenette R; Gauthier JY; Guay J
    J Lipid Mediat; 1993; 6(1-3):239-44. PubMed ID: 8357985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca(2+)/calmodulin-dependent protein kinase (CaM-kinase) inhibitor KN-62 suppresses the activity of mitogen-activated protein kinase (MAPK), c-myc activation and human keratinocyte proliferation.
    Praskova M; Kalenderova S; Miteva L; Poumay Y; Mitev V
    Arch Dermatol Res; 2002 Jul; 294(4):198-202. PubMed ID: 12111351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A calmodulin-like protein as an extracellular mitogen for the keratinocyte.
    Goberdhan NJ; Dawson RA; Freedlander E; Mac Neil S
    Br J Dermatol; 1993 Dec; 129(6):678-88. PubMed ID: 8286250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 10-Phenylbutyryl-substituted anthracenones as inhibitors of keratinocyte growth and LTB(4) biosynthesis.
    Müller K; Breu K; Reindl H
    Eur J Med Chem; 2001 Feb; 36(2):179-84. PubMed ID: 11311748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase 7A inhibitor ASB16165 impairs proliferation of keratinocytes in vitro and in vivo.
    Goto M; Kadoshima-Yamaoka K; Murakawa M; Yoshioka R; Tanaka Y; Inoue H; Murafuji H; Kanki S; Hayashi Y; Nagahira K; Ogata A; Nakatsuka T; Fukuda Y
    Eur J Pharmacol; 2010 May; 633(1-3):93-7. PubMed ID: 20132810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antipsoriatic Mahonia aquifolium and its active constituents; II. Antiproliferative activity against cell growth of human keratinocytes.
    Müller K; Ziereis K; Gawlik I
    Planta Med; 1995 Feb; 61(1):74-5. PubMed ID: 7700998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsoriatic anthrones with modulated redox properties. 3. 10-thio-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of keratinocyte growth, 5-lipoxygenase, and the formation of 12(S)-HETE in mouse epidermis.
    Müller K; Huang HS; Wiegrebe W
    J Med Chem; 1996 Aug; 39(16):3132-8. PubMed ID: 8759634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of trifluoperazine, a calmodulin antagonist, on the growth of normal and malignant epidermal keratinocytes in culture.
    Grief F; Soroff HS; Albers KM; Taichman LB
    Eur J Cancer Clin Oncol; 1989 Jan; 25(1):19-26. PubMed ID: 2920766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine- and adenine-nucleotide-mediated inhibition of normal and transformed keratinocyte proliferation is dependent upon dipyridamole-sensitive adenosine transport.
    Brown JR; Cornell K; Cook PW
    J Invest Dermatol; 2000 Nov; 115(5):849-59. PubMed ID: 11069623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissimilar mechanisms of action of anticalmodulin drugs: quantitative analysis.
    Orosz F; Telegdi M; Liliom K; Solti M; Korbonits D; Ovádi J
    Mol Pharmacol; 1990 Dec; 38(6):910-6. PubMed ID: 2147457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors.
    Mancini JA; Prasit P; Coppolino MG; Charleson P; Leger S; Evans JF; Gillard JW; Vickers PJ
    Mol Pharmacol; 1992 Feb; 41(2):267-72. PubMed ID: 1538707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.